Loading stock data…
HCA Healthcare, Inc. (HCA)
$405.00-4.20 (-1.03%)
Pre-Market$403.25-1.75 (-0.43%)· Last close Sep 4
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
HCA Healthcare, Inc. in the Healthcare sector is trading at $405.00 with a market capitalization of $89.1B. Wall Street consensus targets $451.48 (21 analysts), implying a +11.5% move over the next 12 months. The stock is currently 27% below its 52-week high of $556.52, remaining 10.2% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. Risk note: MACD remains below its signal line. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +11.5% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $20.23B↑ | $19.11B↓ | $19.51B↑ | $19.16B↑ | $18.61B |
| Gross Profit | $9.05B↑ | $7.97B↓ | $8.18B↑ | $8.02B↑ | $7.62B |
| Operating Income | $3.07B↑ | $2.86B↓ | $3.18B↑ | $2.96B | $2.97B |
| Net Income | $1.70B↑ | $1.62B↓ | $1.88B↑ | $1.64B↓ | $1.65B |
Peer Comparison
JNJUNHPFE
Fundamentals
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic a...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$89.14B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
13.91
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.11
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.74%
ROE
Average efficiency. Growth may require heavy reinvestment.
-102.98%
Volume
Today's trading volume
929,122
Recent News
The Bull Case For HCA Healthcare (HCA) Could Change Following 2026 Guidance Cut And Payer Mix Strain
HCA Healthcare recently cut its full-year 2026 earnings guidance, citing a worsening payer mix after Affordable Care Act subsidy expirations, softer high-margin elective surgeries, and rising costs that also prompted targeted corporate and support-function layoffs and at least one hospital divestiture. These actions, alongside an estimated US$400 million quarterly revenue impact from payer shifts and an ongoing legal review of prior disclosures, highlight how policy-driven reimbursement...
HCA Healthcare (HCA) Faces Securities Fraud Investigation With Shareholder Risks In Focus
Pomerantz Law Firm has launched an investigation into potential securities fraud and unlawful business practices at HCA Healthcare (NYSE:HCA). The probe focuses on whether HCA Healthcare and certain executives misled investors or breached fiduciary duties. The investigation could lead to future legal claims on behalf of shareholders depending on its findings. This kind of legal scrutiny highlights broader questions about risk, disclosure and income reliability across the healthcare sector...
HCA Healthcare (HCA) Could Be 11% Below Fair Value As Guidance Gets Cut
HCA Healthcare (HCA) shares remain under pressure after the company cut its 2026 profit guidance, citing a weaker payer mix that reduced quarterly revenue by about $400 million and triggered fresh investor scrutiny. Against that backdrop, HCA Healthcare’s recent share price moves have been choppy, with a 1 day share price return of 1.78% after the guidance cut, a 90 day share price return of 9.96%, and a year to date share price decline of 13.01% at a last close of US$409.20. The 3 year total...
Charles River (CRL) Up 10.5% Since Last Earnings Report: Can It Continue?
Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is HCA Healthcare Stock Underperforming the Nasdaq?
HCA Healthcare has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.